Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
NCT00314522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2016-02-25
Summary
This study performed a retrospective analysis of patient images to develop software in determining dose delivered for each fraction treatment.
Conditions
- Healthy
Sponsors & Collaborators
-
Cross Cancer Institute
collaborator OTHER -
AHS Cancer Control Alberta
lead OTHER
Principal Investigators
-
Gino Fallone, PhD · AHS Cancer Control Alberta
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Completion
- 2006-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
NCT00122265 ·Status: TERMINATED
-
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
NCT00126854 ·Status: COMPLETED ·Phase: NA
-
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
NCT07291557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Hypo-fractionated Postoperative IMRT in Prostate Cancer
NCT03233672 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
NCT00129025 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00214422 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
NCT00126802 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
NCT04557501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
NCT01488968 ·Status: TERMINATED ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00331773 ·Status: COMPLETED ·Phase: PHASE3
-
Imaging of High Grade Prostate Cancer
NCT02177526 ·Status: TERMINATED ·Phase: NA
-
Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy
NCT00126815 ·Status: COMPLETED
-
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NCT05361902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy for Oligometastatic Prostate Cancer
NCT02563691 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
NCT00326638 ·Status: UNKNOWN ·Phase: NA
-
Contrast Enhanced MRI of the Prostate
NCT02245282 ·Status: COMPLETED
-
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NCT03160794 ·Status: RECRUITING ·Phase: NA
-
Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00124917 ·Status: TERMINATED ·Phase: PHASE1
-
Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer
NCT01352429 ·Status: ACTIVE_NOT_RECRUITING
-
Proton Boost in Prostate Cancer
NCT03564275 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
NCT03908684 ·Status: RECRUITING
-
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
NCT06665932 ·Status: RECRUITING ·Phase: NA
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED